Cancer Genetics Inc (NASDAQ:CGIX)

9.22
Delayed Data
As of May 01
 +0.05 / +0.55%
Today’s Change
4.83
Today|||52-Week Range
14.88
+38.02%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 13.00, with a high estimate of 15.75 and a low estimate of 13.00. The median estimate represents a +41.00% increase from the last price of 9.22.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.54
Sales
$3.9M
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.20%
 
 
 
 
 
 
Growthannually -16.37%
 
 
 
 
 

Sales

Growthquarterly -2.34%
 
 
 
 
 
 
Growthannually 92.13%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account